Week In Review: Baiyunshan Pharma Raises $1.6 Billion

Guangzhou Baiyunshan Pharma (HK: 874) will raise $1.6 billion in a secondary offering, which it will use for various corporate initiatives, including expanding its China's online drug selling effort. Yunfeng, the private equity firm co-founded by Alibaba's Jack Ma is an investor.